Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Benjamin Kearns, Katy Cooper, Anna Cantrell & Chloe Thomas. (2021) Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain. Neuropsychiatric Disease and Treatment 17, pages 125-137.
Read now
Read now
Articles from other publishers (5)
Paulo Sousa Martins, Filipa Caldas, Catarina Oliveira, Jorge Mota & Marta Gonçalves. (2022) A 10-year mirror-image study of effectiveness and cost of long-acting paliperidone palmitate injectable in patients with schizophrenia or schizoaffective disorder. Psychiatry Research 312, pages 114581.
Crossref
Crossref
Juan Antonio García-Carmona, Joshua Barnett, María Pilar Campos-Navarro, Katy Mason, Francisco Valdivia-Muñoz & Sofia Pappa. (2022) Comparative effectiveness of long-acting injectable antipsychotics in a large naturalistic cohort across two European centers: Findings from the long-acting injectable antipsychotics collaborative (LAICO) study.. Neuroscience Applied 1, pages 100111.
Crossref
Crossref
Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar & Prakash S. Masand. (2021) Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?. Clinical Psychopharmacology and Neuroscience 19:3, pages 434-448.
Crossref
Crossref
Dalibor Karlović, Ante Silić, Danijel Crnković & Vjekoslav Peitl. (2020) Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia. Human Psychopharmacology: Clinical and Experimental 36:2.
Crossref
Crossref
Katy Mason, Joshua Barnett & Sofia Pappa. (2021) Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate. Therapeutic Advances in Psychopharmacology 11, pages 204512532110294.
Crossref
Crossref